Search

Search Constraints

You searched for: Author/Creator Xu, B

Search Results

3. OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer. (23rd January 2019)

4. P6419Prognostic value of the GRACE discharge score for long-term death in patients with stable coronary artery disease after percutaneous coronary intervention. (28th August 2018)

5. Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al. (25th September 2017)

6. 44PGlobal clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab. (25th November 2018)